Subscribe To
WDNA / Multiple Reasons to Bet on Biotech ETF WDNA
WDNA News
By ETF Trends
September 25, 2023
Multiple Reasons to Bet on Biotech ETF WDNA
The healthcare sector is disappointing this year. And the ICE Biotechnology Index is even more of a dud on a year-to-date basis. more_horizontal
By ETF Trends
January 21, 2022
Rare Valuation Opportunities Afoot in Some Megatrends ETFs
Equities are off to a dismal start to 2022, with high-growth and technology stocks, particularly shares of unprofitable companies, ranking among the w more_horizontal
By ETF Trends
January 21, 2022
Rare Valuation Opportunities Afoot in Some Megatrends ETFs
Equities are off to a dismal start to 2022, with high-growth and technology stocks, particularly shares of unprofitable companies, ranking among the w more_horizontal
By ETF Trends
January 21, 2022
Rare Valuation Opportunities Afoot in Some Megatrends ETFs
Equities are off to a dismal start to 2022, with high-growth and technology stocks, particularly shares of unprofitable companies, ranking among the w more_horizontal
By Seeking Alpha
January 19, 2022
WisdomTree Megatrends: A Pulse Check On Valuations As Interest Rates Rise
While WCLD's valuation premium has meaningfully contracted, its expected revenue growth over the benchmark Index has not. more_horizontal
By Seeking Alpha
January 19, 2022
WisdomTree Megatrends: A Pulse Check On Valuations As Interest Rates Rise
While WCLD's valuation premium has meaningfully contracted, its expected revenue growth over the benchmark Index has not. more_horizontal
By Seeking Alpha
January 19, 2022
WisdomTree Megatrends: A Pulse Check On Valuations As Interest Rates Rise
While WCLD's valuation premium has meaningfully contracted, its expected revenue growth over the benchmark Index has not. more_horizontal